Indian Pharmas Cleared Of Price-Fixing By U.K. Court
This article was originally published in PharmAsia News
A U.K. court denied price-collusion allegations against five pharmaceuticals, including at least two with Indian ties. Goldshield, founded by India's Ajit Patel, and Ranbaxy U.K. were among firms that had been under investigation on price-fixing allegations for more than six years by the Serious Fraud Office. A U.K. court cleared the companies of a conspiracy allegation brought by the National Health Service concerning the prices of antibiotics and other common drugs. The court decided the allegations involved actions that allegedly occurred before the U.K. adopted a law making price-fixing an offense. (Click here for more
You may also be interested in...
Teva received a “package of commercial side-deals” for agreeing to halt generic competition to Cephalon’s Provigil (modafinil) throughout the EU, which it “would not have achieved without committing to staying out of the market,” according to findings by the European Commission.
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma